The integrated system with Tm mapping and the FCS-based NF-kB assay for sepsis patients
Project/Area Number |
25670268
|
Research Category |
Grant-in-Aid for Challenging Exploratory Research
|
Allocation Type | Multi-year Fund |
Research Field |
Laboratory medicine
|
Research Institution | University of Toyama |
Principal Investigator |
KITAJIMA Isao 富山大学, 大学院医学薬学研究部(医学), 教授 (50214797)
|
Co-Investigator(Kenkyū-buntansha) |
NIIMI Hideki 富山大学, 大学病院, 助教 (50401865)
|
Project Period (FY) |
2013-04-01 – 2015-03-31
|
Project Status |
Completed (Fiscal Year 2014)
|
Budget Amount *help |
¥3,640,000 (Direct Cost: ¥2,800,000、Indirect Cost: ¥840,000)
Fiscal Year 2014: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2013: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
Keywords | 感染症 / 微生物 / 敗血症 / 遺伝子検査 / 転写因子 / 1分子計測 / 一分子計測 |
Outline of Final Research Achievements |
The earliest possible identification of pathogenic microorganisms is critical for selecting appropriate antimicrobial therapy. We developed a nested-PCR-based assay for detecting Mycoplasma and other bacteria in amniotic fluid samples using eukaryotic, thermostable DNA polymerase. Next, a "melting temperature (Tm) mapping method" was developed for identifying a broad range of bacteria. Employing primer sets for a 16S ribosomal gene, more than 100 bacterial species can be identified. Nuclear transcription factor-kappa B (NF-kB) activation plays a key role in the regulation of immune responses to inflammation. We developed an experimental apparatus for detection of NF-kB activation based on fluorescence correlation spectroscopy (FCS), which permits analysis of DNA-protein binding in the liquid phase. FCS was performed using the single-molecule fluorescence detention system. We have integrated Tm mapping and the FCS based NF-kB assay and are conducting clinical trials in sepsis patients.
|
Report
(3 results)
Research Products
(17 results)
-
[Journal Article] Post-maketing surveillance of thrombomodulin alfa, a novel drug for treatment of disseminated intravascular coagulation treatment- Safety and efficacy in 1,032 patients assosiated with hematologic malignancy2014
Author(s)
Asakura H, Takahashi H, Matsushita T, Ninomya H, Honda G, Mimuro J, Eguchi Y, Kitajima I, Sakata Y
-
Journal Title
Thromb Res.
Volume: 133
Pages: 364-370
Related Report
Peer Reviewed
-
-
[Journal Article] Post-marketing surveillance data of the thrombomodulin alfa: sub-analysis in patients with sepsis-induced disseminated intravascular coagulation.2014
Author(s)
Eguchi Y, Gando S, Ishikura H, Saitoh D, Mimuro J, Takahashi H, Kitajima I, Tshuji H, Matsushita T, Tsujita R, Nagao O, Sakata Y
-
Journal Title
Journal of Intensive Care.
Volume: 2
Pages: 30-30
Related Report
Peer Reviewed / Open Access
-
[Journal Article] Post-marketing surveillance of thrombomodulin alfa, a novel treatment of disseminated intravascular coagulation - Safety and efficacy in 1,032 patients with hematologic malignancy2014
Author(s)
Asakura H, Takahashi H, Tsuji H, Matsushita T, Ninomiya H, Honda G, Mimuro J, Eguchi Y, Kitajima I, Sakata Y
-
Journal Title
Thromb Res
Volume: 133
Issue: 3
Pages: 364-370
DOI
Related Report
Peer Reviewed / Open Access
-
[Journal Article] N-terminal pro-Brain Natriuretic Peptide as a Predictor of Reoperation in Children With Surgically Corrected Tetralogy of Fallot2014
Author(s)
Hirono K1, Sekine M, Shiba N, Hayashi S, Nakaoka H, Ibuki K, Saito K, Watanabe K, Ozawa S, Higuma T, Yoshimura N, Kitajima I, Ichida F.
-
Journal Title
Circ J
Volume: 78(3)
Pages: 693-700
NAID
Related Report
Peer Reviewed
-
-
-
-
-
-
-
-
-
-
[Presentation] Thrombomodulin Alfa Treatment For Disseminated Intravascular Coagulation In Acute Promyelocytic Leukemia: A Retrospective Analysis Of The Open-Label, Multicenter Study Cohort.2013
Author(s)
Matsushita T, Watanabe J, Goichi Honda, Mimuro J, Takahashi H, Tsuji H, Eguchi Y,, Kitajima I, Sakata Y.
Organizer
55th American Society of Hematology Annual Meeting and Exposition
Place of Presentation
New Orleans, LA, USA.
Related Report
-
-